FOXO TECHNOLOGIES INC.

FOXOW ·Healthcare, Diagnostics & Research, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Operating Activities
Net Income $-12.4M $-12.4M $-26.5M $-95.3M $-38.5M
Depreciation & Amortization $597.4K $1.2M $1.3M $1.5M
Depreciation $100.0K $100.0K $25.6K $1.5M $98.0K
Amortization $32.0K $1.0M $1.3M $1.3M
Stock-Based Compensation $-164.2K $-101.7K $381.4K $11.0M $131.0K
Net Cash from Operating Activities $-3.9M $-2.8M $-6.6M $-23.8M $-15.1M
Investing Activities
Capital Expenditures $62.0K $110.0K $118.0K
Business Acquisitions $-13.3K $63.0K
Net Cash from Investing Activities $-655.6K $13.3K $-1.9M $-355.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $4.7M $2.9M $1.2M $24.3M $14.1M
Net Change in Cash $-1.3M $-779.3K
Free Cash Flow $-3.9M $-23.9M $-15.2M